Caption Management’s Novavax NVAX Stock Holding History

Caption Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-300,000	Closed	-$2.02M	–	1903
2025 Q4	$2.02M	Buy	300,000 +250,000	+500%	+$1.88M	0.01%	835
2025 Q3	$434K	Sell	50,000 -195,000	-80%	-$1.52M	﹤0.01%	1333
2025 Q2	$1.54M	Buy	245,000 +45,000	+23%	+$298K	0.02%	804
2025 Q1	$1.28M	Buy	200,000 +80,000	+67%	+$661K	0.01%	830
2024 Q4	$965K	Sell	120,000 -120,000	-50%	-$1.16M	0.01%	926
2024 Q3	$3.03M	Buy	+240,000	New	+$3.1M	0.05%	441
2021 Q2	–	Sell	-20,100	Closed	-$3.64M	–	1494
2021 Q1	$3.64M	Buy	+20,100	New	+$4.01M	0.08%	330
2020 Q1	–	Sell	-680,000	Closed	-$2.71M	–	1003
2019 Q4	$2.71M	Hold	680,000	–	–	0.09%	302
2019 Q3	$3.41M	Sell	680,000 -250,000	-27%	-$1.37M	0.18%	154
2019 Q2	$5.45M	Buy	930,000 +828,920	+820%	+$6.52M	0.27%	103
2019 Q1	$22.3M	Buy	+101,080	New	+$3.19M	1.23%	8

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's NVAX Position: Q1 2026 in Review

Caption Management increased its Novavax (NVAX) stake by 6.5% in Q1 2026, buying an estimated $82.5K and bringing the position to 148,155 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #960.

Caption Management first reported a position in NVAX in Q4 2018 and has held it in 7 quarters since. The position peaked at $1.4M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Caption Management held 148,155 shares of Novavax worth $1.21M as of Q1 2026.
Caption Management bought 9,105 Novavax shares in Q1 2026, an estimated $82.5K.
Novavax made up 0.01% of Caption Management's portfolio in Q1 2026, its #960 holding.
Caption Management first reported a position in Novavax in Q4 2018 and has held it in 7 quarters since.
Caption Management's Novavax position peaked at $1.4M in Q1 2021.
257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.